JPS59137500A - メチルプレドニソロンのスルホン酸エステルプロドラツグ - Google Patents

メチルプレドニソロンのスルホン酸エステルプロドラツグ

Info

Publication number
JPS59137500A
JPS59137500A JP59009363A JP936384A JPS59137500A JP S59137500 A JPS59137500 A JP S59137500A JP 59009363 A JP59009363 A JP 59009363A JP 936384 A JP936384 A JP 936384A JP S59137500 A JPS59137500 A JP S59137500A
Authority
JP
Japan
Prior art keywords
formula
acid
ester
compound
corticosteroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59009363A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0226639B2 (enExample
Inventor
ブラドレイ・デイル・アンダーソン
ロバート・アレン・コンラジ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS59137500A publication Critical patent/JPS59137500A/ja
Publication of JPH0226639B2 publication Critical patent/JPH0226639B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59009363A 1983-01-21 1984-01-21 メチルプレドニソロンのスルホン酸エステルプロドラツグ Granted JPS59137500A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/459,742 US4472392A (en) 1983-01-21 1983-01-21 Sulfonate containing ester prodrugs of corticosteroids
US459742 1983-01-21

Publications (2)

Publication Number Publication Date
JPS59137500A true JPS59137500A (ja) 1984-08-07
JPH0226639B2 JPH0226639B2 (enExample) 1990-06-12

Family

ID=23825979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59009363A Granted JPS59137500A (ja) 1983-01-21 1984-01-21 メチルプレドニソロンのスルホン酸エステルプロドラツグ

Country Status (8)

Country Link
US (1) US4472392A (enExample)
EP (1) EP0120557B1 (enExample)
JP (1) JPS59137500A (enExample)
CA (1) CA1199908A (enExample)
DE (1) DE3478605D1 (enExample)
HK (1) HK43993A (enExample)
MX (1) MX9203197A (enExample)
ZA (1) ZA838826B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010514674A (ja) * 2006-10-12 2010-05-06 ベラス ヘルス （インターナショナル） リミテッド ３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
US5446177A (en) * 1984-12-28 1995-08-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
AU2138988A (en) * 1987-07-16 1989-02-13 Upjohn Company, The Amine salts of alkane-1,n-dicarboxylic acid mono- (2-sulfato-ethyl)amides
BR9307746A (pt) * 1993-01-08 1995-11-14 Astra Ab Derivados de esteróides especificos para otratamento de cólon e ileo
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
EP1562627A4 (en) * 2002-08-23 2006-11-02 Mclean Hospital Corp CORTICOSTEROID CONJUGATES AND ITS USES
EP1663999A2 (en) * 2003-08-29 2006-06-07 Ranbaxy Laboratories, Ltd. Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
MX2009003100A (es) * 2006-09-22 2009-05-11 Ranbaxy Lab Ltd Inhibidores de fosfodiesterasa tipo iv.
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
AU2008224541B2 (en) 2007-03-14 2013-08-22 Sun Pharmaceutical Industries Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
US20090306579A1 (en) 2008-02-25 2009-12-10 Eyegate Pharmaceuticals, Inc. Delivery of corticosteroids through iontophoresis
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
WO2022037704A1 (zh) * 2020-08-21 2022-02-24 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids
US2986559A (en) * 1959-01-07 1961-05-30 Schering Corp Novel therapeutic salts and processes for their manufacture
US3171846A (en) * 1962-07-10 1965-03-02 Erba Carlo Spa Prednisolone-21-double esters
NL124139C (enExample) * 1964-11-04
FR6590M (enExample) * 1967-10-31 1968-12-30
US3609712A (en) * 1969-01-15 1971-09-28 Ibm Insulated gate field effect transistor memory array
US4221787A (en) * 1978-03-28 1980-09-09 Interx Research Corporation Esteramide prodrugs of anti-inflammatory corticosteroids
SU818489A3 (ru) * 1978-10-04 1981-03-30 Шеринг Аг (Фирма) Способ получени кортикоид -21- СульфОпРОпиОНАТОВ или иХ СОлЕй
DE2848423A1 (de) * 1978-11-08 1980-05-29 Merck Patent Gmbh Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010514674A (ja) * 2006-10-12 2010-05-06 ベラス ヘルス （インターナショナル） リミテッド ３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
US8748656B2 (en) 2006-10-12 2014-06-10 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
JP2015007047A (ja) * 2006-10-12 2015-01-15 ビーエイチアイ リミテッド パートナーシップ ３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
US10238611B2 (en) 2006-10-12 2019-03-26 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10857109B2 (en) 2006-10-12 2020-12-08 Bellus Health, Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US11020360B2 (en) 2006-10-12 2021-06-01 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Also Published As

Publication number Publication date
US4472392A (en) 1984-09-18
DE3478605D1 (en) 1989-07-13
JPH0226639B2 (enExample) 1990-06-12
EP0120557A3 (en) 1985-02-06
HK43993A (en) 1993-05-14
MX9203197A (es) 1992-09-01
ZA838826B (en) 1984-07-25
EP0120557A2 (en) 1984-10-03
EP0120557B1 (en) 1989-06-07
CA1199908A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
JPS59137500A (ja) メチルプレドニソロンのスルホン酸エステルプロドラツグ
JP4388600B2 (ja) コルチコイド化合物の硝酸エステル類およびその薬学的使用
DE2912331A1 (de) Neue 17 beta -thiocarboxylate von 3-oxo-androst-4-en- bzw. -androsta-1,4-dienderivaten, ihre herstellung und diese enthaltende arzneimittel
CA1202616A (en) Sulfonate containing ester prodrugs of corticosteroids
WO1990015816A1 (en) Suramin type compounds and angiostatic steroids to inhibit angiogenesis
DE3510978A1 (de) Neue 9-halogenprostaglandine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0156643A2 (en) Ester prodrugs of steroids
WO1996003421A1 (en) Neurologically active aminosteroids
EP0106453B1 (en) 21-hydroxycorticosteroid esters, and compositions containing them
US4443440A (en) Amine containing ester prodrugs of corticosteroids
CN101300265A (zh) 糖皮质激素硝酰氧基衍生物
EP0909764B1 (de) 11 Beta-Benzaldoxim-9 Alpha, 10 Alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
US4588718A (en) Carboxy containing ester prodrugs of corticosteroids
US3354201A (en) p-dihydroxybenzene-sulfonate of diethylamine
US5776922A (en) Corticoid derivatives and pharmaceutical and cosmetic compositions
DE4434488A1 (de) Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JP3096480B2 (ja) 胆汁酸不飽和誘導体、その製造方法、およびそれらを含有する製薬組成物
JPH07252294A (ja) 副腎皮質ステロイド誘導体
JPS5817480B2 (ja) コルチコステロイド ２１− エステルユウドウタイノ セイゾウホウ
JPS6363698A (ja) 胆汁酸誘導体およびその塩ならびにその製造法
CA1113452A (en) Water-soluble corticoids
JPS6360995A (ja) ２１−置換チオステロイド化合物
HK1132449A (en) Preventive/therapeutic agent for inflammatory respiratory tract diseases
JPWO1999052863A1 (ja) ２β位に置換基を有するビタミンＤ誘導体